The Health Ministry is examining the US court order related to violation of USFDA drug safety norms by Ranbaxy at its manufacturing units in India but is yet to order a probe into the matter.
“Right now, we are looking into the US court order against Ranbaxy and whether there has been any violation of Indian laws,” a health ministry official said.
The ministry has also asked the Drug Controller General of India (DCGI) to examine the US court order to determine whether any Indian laws were violated by the drug production facilities in Himachal Pradesh and Madhya Pradesh, the official said.
“If there is any violation, then a probe would be ordered,” the official said.